文献速递皮肤肿瘤

「Get Data Out」皮肤项目:2013-2019年英格兰所有登记皮肤肿瘤组的国家癌症登记发病率与生存率

'Get Data Out' Skin: national cancer registry incidence and survival rates for all registered skin tumour groups for 2013-2019 in England.
PubMed 文献 · Br J Dermatol · 2023-01-01

该研究基于英格兰国家癌症登记数据,对2013-2019年登记的皮肤肿瘤按肿瘤类型和患者特征进行共识分类,计算发病率、生存率和转诊途径。共登记1 445 377例皮肤癌和49 123例癌前病变及未定义病变,多数肿瘤发病率上升;基底细胞癌最常见(2019年发病率282.36/10万人年),基底细胞癌生存极好,晚期黑色素瘤、默克尔细胞癌和生殖器皮肤鳞状细胞癌5年净生存率低于60%。

要点

  • 2019年基底细胞癌发病率282.36/10万人年,皮肤鳞状细胞癌85.24/10万人年,黑色素瘤27.24/10万人年。
  • 皮肤鳞状细胞癌5年净生存率89.8%与所有黑色素瘤的89.6%相当,基底细胞癌总体净生存率超过100%。
  • 晚期黑色素瘤、默克尔细胞癌和生殖器皮肤鳞状细胞癌的5年净生存率低于60%。

核心结论

  • 「Get Data Out」皮肤项目提供了英格兰所有可登记皮肤肿瘤的详细最新统计数据,首次纳入癌前病变和常见癌症的罕见亚型。

研究设计与样本

  • 基于英格兰国家癌症登记数据,将具有皮肤拓扑编码(ICD-10)及形态学和行为编码(ICD-O3)的肿瘤通过迭代过程分组为分层树结构。
  • 研究期间为2013年至2019年,共登记1 445 377例皮肤癌和49 123例癌前病变及未定义病变。
  • 按分组计算发病例数、Kaplan-Meier和净生存估计以及转诊途径(两周等待、全科医生、门诊)分类。

主要发现

  • 大多数肿瘤类型的皮肤肿瘤和皮肤癌发病率在上升。
  • 2019年基底细胞癌发病率282.36/10万人年(n=158 934,95%CI 280.98-283.76),皮肤鳞状细胞癌85.24/10万人年(n=47 977,95%CI 84.48-86.00),黑色素瘤27.24/10万人年(n=15 332,95%CI 26.81-27.67)。
  • 每年约登记1800例罕见皮肤癌、1500例生殖器皮肤鳞状细胞癌和100例乳房外Paget病。
  • 每年15 000例黑色素瘤中,120例发生于年龄小于25岁的个体。
  • 皮肤鳞状细胞癌5年净生存率89.8%(95%CI 88.8-90.9)与所有黑色素瘤的89.6%(95%CI 88.7-90.6)相当;基底细胞癌总体净生存率超过100%;晚期黑色素瘤、默克尔细胞癌和生殖器皮肤鳞状细胞癌的5年净生存率低于60%。

临床怎么用

  • 作者认为这些数据可供临床医生、研究人员和委托方用于更好地理解皮肤癌并改善资源分配。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Providing detailed skin cancer statistics, including incidence and survival, by tumour type and patient characteristics is important for up-to-date epidemiological information. OBJECTIVES: To create a new clinically relevant consensus-based classification for registered skin tumours using tumour type and patient characteristics and to describe its application to all registered tumours in England between 2013 and 2019. METHODS: Tumours with skin topographical codes (ICD-10) and morphology and behaviour (ICD-O3) were grouped together in an iterative process creating a hierarchical tree structure. The primary-level grouping partitioned skin tumours into skin cancer, melanoma in situ, extramammary Paget disease (EMPD) and tumours of uncertain malignant potential. Second-level groups split skin cancer into keratinocyte cancer (KC), melanoma and rare cancers. The third-level group split KC into basal cell carcinoma (BCC) and squamous cell carcinoma (cSCC). Further groups were split into genital or non-genital, first or subsequent tumour, age, gender, stage, or National Health Service (NHS) region. Incidence counts, Kaplan-Meier and net survival estimates and referral routes [two-week wait (TWW), general practitioner (GP), outpatient] categorisations were calculated for each grouping across all years. RESULTS: A total of 1 445 377 skin cancers and 49 123 precancerous lesions and undefined entities were registered in England between 2013 and 2019. Skin tumours and skin cancer incidence rates are increasing for most tumour types. The most common type of skin cancer was BCC with an incidence rate of 282.36 per 100 000 person-years (PYs) [n = 158 934, 95% confidence interval (CI) 280.98-283.76] in 2019, followed by cSCC with an incidence rate of 85.24 per 100 000 PYs (n = 47 977, 95% CI 84.48-86.00) and melanoma with 27.24 (n = 15 332, 95% CI 26.81-27.67) per 100 000 PYs. Each year approximately 1800 rare skin cancers, 1500 genital cSCCs and 100 cases of EMPD are registered. Of 15 000 melanoma cases, 120 cases of melanoma occur in individuals aged < 25 years annually. One-year and five-year overall net survival varies by tumour type. cSCC 5-year net survival (89.8%, 95% CI 88.8-90.9) was comparable to the net survival of all melanomas (89.6%, 95% CI 88.7-90.6). BCC had excellent survival (overall net survival > 100%). Patients with late-stage melanoma, Merkel cell carcinoma and genital cSCC have a 5-year net survival < 60%. Older patients received fewer TWW referrals than their younger counterparts with the same tumour type at the same location. Patients with acral lentiginous melanoma had fewer TWW referrals and more standard GP referrals than patients with common melanomas. CONCLUSIONS: 'Get Data Out' Skin provides detailed and up-to-date statistics on all registrable skin tumours in England, including for the first time precancerous lesions and rare subtypes of common cancers. These data can be used by clinicians, researchers and commissioners to better understand skin cancer and improve resource allocation.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. van Bodegraven B, Vernon S, Eversfield C, et al. 'Get Data Out' Skin: national cancer registry incidence and survival rates for all registered skin tumour groups for 2013-2019 in England. Br J Dermatol. 2023. PMID: 36814132. doi:10.1093/bjd/ljad033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。